These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18067924)

  • 1. The role of cytoprotective cytokines in cardiac ischemia/reperfusion injury.
    Anderson CD; Heydarkhan-Hagvall S; Schenke-Layland K; Yang JQ; Jordan MC; Kim JK; Brown DA; Zuk PA; Laks H; Roos KP; Maclellan WR; Beygui RE
    J Surg Res; 2008 Aug; 148(2):164-71. PubMed ID: 18067924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.
    Wang Y; Ahmad N; Wani MA; Ashraf M
    J Mol Cell Cardiol; 2004 Nov; 37(5):1041-52. PubMed ID: 15522281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF.
    Nakamura T; Mizuno S; Matsumoto K; Sawa Y; Matsuda H; Nakamura T
    J Clin Invest; 2000 Dec; 106(12):1511-9. PubMed ID: 11120758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydroxyflavonol reduces post-infarction left ventricular remodeling by preventing myocyte apoptosis in the non-infarcted zone in goats.
    Wang S; Fei K; Xu YW; Wang LX; Chen YQ
    Chin Med J (Engl); 2009 Jan; 122(1):61-7. PubMed ID: 19187619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
    Deuse T; Peter C; Fedak PW; Doyle T; Reichenspurner H; Zimmermann WH; Eschenhagen T; Stein W; Wu JC; Robbins RC; Schrepfer S
    Circulation; 2009 Sep; 120(11 Suppl):S247-54. PubMed ID: 19752375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cells improve right ventricular functional recovery after acute pressure overload and ischemia reperfusion injury.
    Wairiuko GM; Crisostomo PR; Wang M; Morrell ED; Meldrum KK; Lillemoe KD; Meldrum DR
    J Surg Res; 2007 Aug; 141(2):241-6. PubMed ID: 17583739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early treatment with hepatocyte growth factor improves cardiac function in experimental heart failure induced by myocardial infarction.
    Jin H; Yang R; Li W; Ogasawara AK; Schwall R; Eberhard DA; Zheng Z; Kahn D; Paoni NF
    J Pharmacol Exp Ther; 2003 Feb; 304(2):654-60. PubMed ID: 12538818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.
    Yang ZJ; Ma DC; Wang W; Xu SL; Zhang YQ; Chen B; Zhou F; Zhu TB; Wang LS; Xu ZQ; Zhang FM; Cao KJ; Ma WZ
    Gene Ther; 2006 Nov; 13(22):1564-8. PubMed ID: 16810195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
    Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX
    Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction.
    Kanellakis P; Slater NJ; Du XJ; Bobik A; Curtis DJ
    Cardiovasc Res; 2006 Apr; 70(1):117-25. PubMed ID: 16497284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
    Li Y; Takemura G; Kosai K; Yuge K; Nagano S; Esaki M; Goto K; Takahashi T; Hayakawa K; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Mizuguchi H; Fujiwara T; Fujiwara H
    Circulation; 2003 May; 107(19):2499-506. PubMed ID: 12695295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hepatocyte growth factor overexpressed bone marrow-derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts.
    Wang S; Qin X; Sun D; Wang Y; Xie X; Fan W; Wang Y; Liang D; Pei X; Cao F
    Cell Biochem Funct; 2012 Oct; 30(7):574-81. PubMed ID: 22592978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
    Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
    J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin inhibits myocardial ischemia-induced apoptosis and alleviates chronic adverse changes in post-ischemic cardiac structure and function.
    Xing W; Yan W; Fu F; Jin Y; Ji L; Liu W; Wang L; Lv A; Duan Y; Zhang J; Zhang H; Gao F
    Apoptosis; 2009 Sep; 14(9):1050-60. PubMed ID: 19590963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions.
    Chen XH; Minatoguchi S; Kosai K; Yuge K; Takahashi T; Arai M; Wang N; Misao Y; Lu C; Onogi H; Kobayashi H; Yasuda S; Ezaki M; Ushikoshi H; Takemura G; Fujiwara T; Fujiwara H
    J Card Fail; 2007 Dec; 13(10):874-83. PubMed ID: 18068622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure.
    Jayasankar V; Woo YJ; Pirolli TJ; Bish LT; Berry MF; Burdick J; Gardner TJ; Sweeney HL
    J Card Surg; 2005; 20(1):93-101. PubMed ID: 15673421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Guo YH; He JG; Wu JL; Yang L; Zhang DS; Tan XY; Qi RD
    Cytotherapy; 2008; 10(8):857-67. PubMed ID: 18956268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naive rat amnion-derived cell transplantation improved left ventricular function and reduced myocardial scar of postinfarcted heart.
    Fujimoto KL; Miki T; Liu LJ; Hashizume R; Strom SC; Wagner WR; Keller BB; Tobita K
    Cell Transplant; 2009; 18(4):477-86. PubMed ID: 19622235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases.
    Son BR; Marquez-Curtis LA; Kucia M; Wysoczynski M; Turner AR; Ratajczak J; Ratajczak MZ; Janowska-Wieczorek A
    Stem Cells; 2006 May; 24(5):1254-64. PubMed ID: 16410389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.